APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Patent Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chinese Patent Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchChinese Patent Medicine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Patent Medicine Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Chinese Patent Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Patent Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Patent Medicine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Chinese Patent Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chinese Patent Medicine include Chongqing Pharmaceutical Co., Ltd, China Pharmaceutical Group Corporation, Xinhualu Anti-Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Shijiazhuang Pharmaceutical Group Co., Ltd., Shanghai Pharmaceutical (Group) Co., Ltd., Nanjing Pharmaceutical Co., Ltd and Nanjing Pharmaceutical Industry (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Patent Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Patent Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Patent Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Patent Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Patent Medicine Segment by Company

Chongqing Pharmaceutical Co., Ltd

China Pharmaceutical Group Corporation

Xinhualu Anti-Pharmaceutical Group Co., Ltd.

Tianjin Pharmaceutical Group Co., Ltd.

Taiji Group Co., Ltd.

Shijiazhuang Pharmaceutical Group Co., Ltd.

Shanghai Pharmaceutical (Group) Co., Ltd.

Nanjing Pharmaceutical Co., Ltd

Nanjing Pharmaceutical Industry (Group) Co., Ltd.

Jiangxi Pharmaceutical Group Corporation

Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

North China Pharmaceutical Group Co., Ltd.

Hangzhou Huadong Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd

Guangzhou Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group Co., Ltd.

Chinese Patent Medicine Segment by Type

Liquid

Tablet

Syrup

Others

Chinese Patent Medicine Segment by Application

Online Sales

Offline Sales

Chinese Patent Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Patent Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Patent Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Patent Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Patent Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chinese Patent Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chinese Patent Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chinese Patent Medicine Industry Trends Table 2. Chinese Patent Medicine Industry Drivers Table 3. Chinese Patent Medicine Industry Opportunities and Challenges Table 4. Chinese Patent Medicine Industry Restraints Table 5. Global Chinese Patent Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chinese Patent Medicine Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Chinese Patent Medicine Sales Market Share by Manufacturers Table 9. Global Chinese Patent Medicine Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Chinese Patent Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chinese Patent Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chinese Patent Medicine Manufacturers, Product Type & Application Table 13. Global Chinese Patent Medicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Patent Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liquid Table 17. Major Manufacturers of Tablet Table 18. Major Manufacturers of Syrup Table 19. Major Manufacturers of Others Table 20. Global Chinese Patent Medicine Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 22. Global Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 23. Global Chinese Patent Medicine Sales Market Share by Type (2021-2026) Table 24. Global Chinese Patent Medicine Sales Market Share by Type (2027-2032) Table 25. Global Chinese Patent Medicine Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 26. Global Chinese Patent Medicine Revenue by Type (2021-2026) & (k tons) Table 27. Global Chinese Patent Medicine Revenue by Type (2027-2032) & (k tons) Table 28. Global Chinese Patent Medicine Revenue Market Share by Type (2021-2026) Table 29. Global Chinese Patent Medicine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Online Sales Table 31. Major Manufacturers of Offline Sales Table 32. Global Chinese Patent Medicine Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 34. Global Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 35. Global Chinese Patent Medicine Sales Market Share by Application (2021-2026) Table 36. Global Chinese Patent Medicine Sales Market Share by Application (2027-2032) Table 37. Global Chinese Patent Medicine Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global Chinese Patent Medicine Revenue by Application (2021-2026) & (k tons) Table 39. Global Chinese Patent Medicine Revenue by Application (2027-2032) & (k tons) Table 40. Global Chinese Patent Medicine Revenue Market Share by Application (2021-2026) Table 41. Global Chinese Patent Medicine Revenue Market Share by Application (2027-2032) Table 42. Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Chinese Patent Medicine Sales by Region (2021-2026) & (k tons) Table 44. Global Chinese Patent Medicine Sales Market Share by Region (2021-2026) Table 45. Global Chinese Patent Medicine Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global Chinese Patent Medicine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 49. North America Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 50. Europe Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 52. Europe Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 59. Global Chinese Patent Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Chinese Patent Medicine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Chinese Patent Medicine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Chinese Patent Medicine Revenue Market Share by Region (2021-2026) Table 63. Global Chinese Patent Medicine Revenue Market Share by Region (2027-2032) Table 64. Chongqing Pharmaceutical Co., Ltd Company Information Table 65. Chongqing Pharmaceutical Co., Ltd Business Overview Table 66. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 68. Chongqing Pharmaceutical Co., Ltd Recent Development Table 69. China Pharmaceutical Group Corporation Company Information Table 70. China Pharmaceutical Group Corporation Business Overview Table 71. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 73. China Pharmaceutical Group Corporation Recent Development Table 74. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information Table 75. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview Table 76. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 78. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development Table 79. Tianjin Pharmaceutical Group Co., Ltd. Company Information Table 80. Tianjin Pharmaceutical Group Co., Ltd. Business Overview Table 81. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 83. Tianjin Pharmaceutical Group Co., Ltd. Recent Development Table 84. Taiji Group Co., Ltd. Company Information Table 85. Taiji Group Co., Ltd. Business Overview Table 86. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 88. Taiji Group Co., Ltd. Recent Development Table 89. Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information Table 90. Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview Table 91. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 93. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development Table 94. Shanghai Pharmaceutical (Group) Co., Ltd. Company Information Table 95. Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview Table 96. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 98. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development Table 99. Nanjing Pharmaceutical Co., Ltd Company Information Table 100. Nanjing Pharmaceutical Co., Ltd Business Overview Table 101. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 103. Nanjing Pharmaceutical Co., Ltd Recent Development Table 104. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information Table 105. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview Table 106. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 108. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development Table 109. Jiangxi Pharmaceutical Group Corporation Company Information Table 110. Jiangxi Pharmaceutical Group Corporation Business Overview Table 111. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 113. Jiangxi Pharmaceutical Group Corporation Recent Development Table 114. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information Table 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview Table 116. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 118. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development Table 119. North China Pharmaceutical Group Co., Ltd. Company Information Table 120. North China Pharmaceutical Group Co., Ltd. Business Overview Table 121. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 123. North China Pharmaceutical Group Co., Ltd. Recent Development Table 124. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information Table 125. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview Table 126. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 128. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development Table 129. Harbin Pharmaceutical Group Co., Ltd Company Information Table 130. Harbin Pharmaceutical Group Co., Ltd Business Overview Table 131. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio Table 133. Harbin Pharmaceutical Group Co., Ltd Recent Development Table 134. Guangzhou Pharmaceutical Group Co., Ltd. Company Information Table 135. Guangzhou Pharmaceutical Group Co., Ltd. Business Overview Table 136. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 138. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development Table 139. Northeast Pharmaceutical Group Co., Ltd. Company Information Table 140. Northeast Pharmaceutical Group Co., Ltd. Business Overview Table 141. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 143. Northeast Pharmaceutical Group Co., Ltd. Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Chinese Patent Medicine Distributors List Table 147. Chinese Patent Medicine Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Chinese Patent Medicine Product Image Figure 2. Global Chinese Patent Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Patent Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Patent Medicine Sales (2021-2032) & (k tons) Figure 5. Global Chinese Patent Medicine Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Chinese Patent Medicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liquid Image Figure 9. Tablet Image Figure 10. Syrup Image Figure 11. Others Image Figure 12. Global Chinese Patent Medicine Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Chinese Patent Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Chinese Patent Medicine Sales Market Share by Type (2021-2032) Figure 15. Global Chinese Patent Medicine Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global Chinese Patent Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Chinese Patent Medicine Revenue Market Share by Type (2021-2032) Figure 18. Online Sales Image Figure 19. Offline Sales Image Figure 20. Global Chinese Patent Medicine Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Chinese Patent Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Chinese Patent Medicine Sales Market Share by Application (2021-2032) Figure 23. Global Chinese Patent Medicine Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Chinese Patent Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Chinese Patent Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America Chinese Patent Medicine Sales Market Share by Country (2021-2032) Figure 28. U.S. Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Chinese Patent Medicine Sales Market Share by Country (2021-2032) Figure 33. Germany Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Chinese Patent Medicine Sales Market Share by Country (2021-2032) Figure 40. China Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2021-2032) Figure 48. Brazil Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile Chinese Patent Medicine Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global Chinese Patent Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Chinese Patent Medicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Figure 59. North America Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Chinese Patent Medicine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Chinese Patent Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Tablet
  • Syrup
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Chongqing Pharmaceutical Co., Ltd
  • China Pharmaceutical Group Corporation
  • Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  • Tianjin Pharmaceutical Group Co., Ltd.
  • Taiji Group Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Co., Ltd.
  • Shanghai Pharmaceutical (Group) Co., Ltd.
  • Nanjing Pharmaceutical Co., Ltd
  • Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  • Jiangxi Pharmaceutical Group Corporation
  • Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  • North China Pharmaceutical Group Co., Ltd.
  • Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd
  • Guangzhou Pharmaceutical Group Co., Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chinese Patent Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chinese Patent Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chinese Patent Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chinese Patent Medicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chinese Patent Medicine Market Dynamics
  1. 2.1 Chinese Patent Medicine Industry Trends
  2. 2.2 Chinese Patent Medicine Industry Drivers
  3. 2.3 Chinese Patent Medicine Industry Opportunities and Challenges
  4. 2.4 Chinese Patent Medicine Industry Restraints
3 Chinese Patent Medicine Market by Manufacturers
  1. 3.1 Global Chinese Patent Medicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chinese Patent Medicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chinese Patent Medicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chinese Patent Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chinese Patent Medicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chinese Patent Medicine Manufacturers, Product Type & Application
  7. 3.7 Global Chinese Patent Medicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chinese Patent Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chinese Patent Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chinese Patent Medicine Tier 1, Tier 2, and Tier 3
4 Chinese Patent Medicine Market by Type
  1. 4.1 Chinese Patent Medicine Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Tablet
  4. 4.1.3 Syrup
  5. 4.1.4 Others
  6. 4.2 Global Chinese Patent Medicine Sales by Type
  7. 4.2.1 Global Chinese Patent Medicine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chinese Patent Medicine Sales by Type (2021-2032)
  9. 4.2.3 Global Chinese Patent Medicine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Chinese Patent Medicine Revenue by Type
  11. 4.3.1 Global Chinese Patent Medicine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chinese Patent Medicine Revenue by Type (2021-2032)
  13. 4.3.3 Global Chinese Patent Medicine Revenue Market Share by Type (2021-2032)
5 Chinese Patent Medicine Market by Application
  1. 5.1 Chinese Patent Medicine Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Chinese Patent Medicine Sales by Application
  5. 5.2.1 Global Chinese Patent Medicine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Patent Medicine Sales by Application (2021-2032)
  7. 5.2.3 Global Chinese Patent Medicine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Chinese Patent Medicine Revenue by Application
  9. 5.3.1 Global Chinese Patent Medicine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chinese Patent Medicine Revenue by Application (2021-2032)
  11. 5.3.3 Global Chinese Patent Medicine Revenue Market Share by Application (2021-2032)
6 Global Chinese Patent Medicine Sales by Region
  1. 6.1 Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Patent Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Patent Medicine Sales by Region (2021-2026)
  4. 6.2.2 Global Chinese Patent Medicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chinese Patent Medicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chinese Patent Medicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chinese Patent Medicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chinese Patent Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chinese Patent Medicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chinese Patent Medicine Revenue by Region
  1. 7.1 Global Chinese Patent Medicine Revenue by Region
  2. 7.1.1 Global Chinese Patent Medicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chinese Patent Medicine Revenue by Region (2021-2026)
  4. 7.1.3 Global Chinese Patent Medicine Revenue by Region (2027-2032)
  5. 7.1.4 Global Chinese Patent Medicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chinese Patent Medicine Revenue (2021-2032)
  8. 7.2.2 North America Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chinese Patent Medicine Revenue (2021-2032)
  11. 7.3.2 Europe Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chinese Patent Medicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chinese Patent Medicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chinese Patent Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Pharmaceutical Co., Ltd
  2. 8.1.1 Chongqing Pharmaceutical Co., Ltd Company Information
  3. 8.1.2 Chongqing Pharmaceutical Co., Ltd Business Overview
  4. 8.1.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  6. 8.1.5 Chongqing Pharmaceutical Co., Ltd Recent Developments
  7. 8.2 China Pharmaceutical Group Corporation
  8. 8.2.1 China Pharmaceutical Group Corporation Company Information
  9. 8.2.2 China Pharmaceutical Group Corporation Business Overview
  10. 8.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  12. 8.2.5 China Pharmaceutical Group Corporation Recent Developments
  13. 8.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  18. 8.3.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Tianjin Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Tianjin Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Tianjin Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  24. 8.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Taiji Group Co., Ltd.
  26. 8.5.1 Taiji Group Co., Ltd. Company Information
  27. 8.5.2 Taiji Group Co., Ltd. Business Overview
  28. 8.5.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  30. 8.5.5 Taiji Group Co., Ltd. Recent Developments
  31. 8.6 Shijiazhuang Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  36. 8.6.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Shanghai Pharmaceutical (Group) Co., Ltd.
  38. 8.7.1 Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
  39. 8.7.2 Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview
  40. 8.7.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  42. 8.7.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
  43. 8.8 Nanjing Pharmaceutical Co., Ltd
  44. 8.8.1 Nanjing Pharmaceutical Co., Ltd Company Information
  45. 8.8.2 Nanjing Pharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  48. 8.8.5 Nanjing Pharmaceutical Co., Ltd Recent Developments
  49. 8.9 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  50. 8.9.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
  51. 8.9.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview
  52. 8.9.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  54. 8.9.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
  55. 8.10 Jiangxi Pharmaceutical Group Corporation
  56. 8.10.1 Jiangxi Pharmaceutical Group Corporation Company Information
  57. 8.10.2 Jiangxi Pharmaceutical Group Corporation Business Overview
  58. 8.10.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  60. 8.10.5 Jiangxi Pharmaceutical Group Corporation Recent Developments
  61. 8.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  62. 8.11.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
  63. 8.11.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview
  64. 8.11.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  66. 8.11.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
  67. 8.12 North China Pharmaceutical Group Co., Ltd.
  68. 8.12.1 North China Pharmaceutical Group Co., Ltd. Company Information
  69. 8.12.2 North China Pharmaceutical Group Co., Ltd. Business Overview
  70. 8.12.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  72. 8.12.5 North China Pharmaceutical Group Co., Ltd. Recent Developments
  73. 8.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  74. 8.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
  75. 8.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview
  76. 8.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  78. 8.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
  79. 8.14 Harbin Pharmaceutical Group Co., Ltd
  80. 8.14.1 Harbin Pharmaceutical Group Co., Ltd Company Information
  81. 8.14.2 Harbin Pharmaceutical Group Co., Ltd Business Overview
  82. 8.14.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
  84. 8.14.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments
  85. 8.15 Guangzhou Pharmaceutical Group Co., Ltd.
  86. 8.15.1 Guangzhou Pharmaceutical Group Co., Ltd. Company Information
  87. 8.15.2 Guangzhou Pharmaceutical Group Co., Ltd. Business Overview
  88. 8.15.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  90. 8.15.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
  91. 8.16 Northeast Pharmaceutical Group Co., Ltd.
  92. 8.16.1 Northeast Pharmaceutical Group Co., Ltd. Company Information
  93. 8.16.2 Northeast Pharmaceutical Group Co., Ltd. Business Overview
  94. 8.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  96. 8.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Patent Medicine Value Chain Analysis
  2. 9.1.1 Chinese Patent Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Patent Medicine Production Mode & Process
  6. 9.2 Chinese Patent Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Patent Medicine Distributors
  9. 9.2.3 Chinese Patent Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst